AbbVie Inc. - stock earnings

ABBV Quarterly earnings

DateEarningsRevenue
2020Q3 2.3 billion USD 12.9 billion USD
2020Q4 36.0 million USD 13.9 billion USD
2021Q1 3.6 billion USD 13.0 billion USD
2021Q2 766.0 million USD 14.0 billion USD
2021Q3 3.2 billion USD 14.3 billion USD
2021Q4 4.0 billion USD 14.9 billion USD
2022Q1 4.5 billion USD 13.5 billion USD

ABBV Yearly earnings

DateEarningsRevenue
2017 5.3 billion USD 28.2 billion USD
2018 5.7 billion USD 32.8 billion USD
2019 7.9 billion USD 33.3 billion USD
2020 4.6 billion USD 45.8 billion USD
2021 11.5 billion USD 56.2 billion USD

ABBV

List: Contenders

Price: 153.80USD

52 week range price:
105.56
175.91

Dividend Yield: 3.37%

Forward Dividend Yield: 3.67%

Payout Ratio: 40.37%

Payout Ratio Range:
37.36%
191.18%

Dividend Per Share: 5.64 USD

Earnings Per Share: 13.97 USD

P/E Ratio: 36.50

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers—General

Volume: 7.3 million

Ebitda: 1.9 billion

Market Capitalization: 270.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 10

DGR3: 13.22%

DGR5: 18.44%

Links: